Literature DB >> 21604177

Adiposity and the risk of colorectal adenomatous polyps: a meta-analysis.

Yeon Ji Lee1, Seung-Kwon Myung, BeLong Cho, Byung-Joo Park, Jin Ho Park, Woong Ju, Min-Sun Park, Ji-Ho Choi.   

Abstract

OBJECTIVE: The findings from epidemiological studies addressing the association between adiposity and the risk of colorectal adenomatous polyps are inconsistent. We performed a meta-analysis of epidemiological studies including cross-sectional, case-control, and cohort studies.
METHODS: We searched PubMed and EMBASE in June, 2010. All searched articles were reviewed and selected independently by two evaluators according to pre-determined selection criteria.
RESULTS: We included 25 studies (nine cross-sectional studies, eleven case-control studies, and five prospective cohort studies) that comprised a total of 300,671 participants and 20,903 cases in the final analysis. When all studies were pooled, the odds ratio (OR) or relative risk (RR) of adiposity and abdominal adiposity for colorectal adenomatous polyp risk was 1.43 (95% confidence interval (CI) 1.23-1.67; n = 22) and 1.42 (95% CI 1.30-1.56; n = 12), respectively. Similarly, an increased risk of colorectal adenomatous polyps was observed in most of the subgroup meta-analyses.
CONCLUSIONS: Overall, we found that adiposity and abdominal adiposity significantly increased the risk of colorectal adenomatous polyps in a meta-analysis of epidemiological studies.

Entities:  

Mesh:

Year:  2011        PMID: 21604177     DOI: 10.1007/s10552-011-9777-9

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  8 in total

1.  Myeloperoxidase-positive cell infiltration of normal colorectal mucosa is related to body fatness and is predictive of adenoma occurrence.

Authors:  F Mariani; V Boarino; A Bertani; A Merighi; M Pedroni; G Rossi; S Mancini; P Sena; P Benatti; L Roncucci
Journal:  Int J Obes (Lond)       Date:  2017-03-30       Impact factor: 5.095

2.  Relationship between body mass index and the risk of early gastric cancer and dysplasia regardless of Helicobacter pylori infection.

Authors:  Hee Jin Kim; Nayoung Kim; Hyun Young Kim; Hye Seung Lee; Hyuk Yoon; Cheol Min Shin; Young Soo Park; Do Joong Park; Hyung Ho Kim; Kyoung-Ho Lee; Young-Hoon Kim; Hee Man Kim; Dong Ho Lee
Journal:  Gastric Cancer       Date:  2014-09-21       Impact factor: 7.370

3.  Colorectal adenomas and diabetes: implications for disease prevention.

Authors:  R J C Steele; A S Anderson; M Macleod; A M Craigie; S Caswell; J Belch; S Treweek
Journal:  Colorectal Dis       Date:  2015-07       Impact factor: 3.788

4.  Emerging trends in colorectal cancer: Dysregulated signaling pathways (Review).

Authors:  Rehan Ahmad; Jaikee Kumar Singh; Amoolya Wunnava; Omar Al-Obeed; Maha Abdulla; Sandeep Kumar Srivastava
Journal:  Int J Mol Med       Date:  2021-01-07       Impact factor: 4.101

5.  The Association of Waist Circumference with the Prevalence and Survival of Digestive Tract Cancer in US Adults: A Population Study Based on Machine Learning Methods.

Authors:  Xingyu Jiang; Qi Liang; Huanhuan Xu; Shouyong Gu; Lingxiang Liu
Journal:  Comput Math Methods Med       Date:  2022-10-06       Impact factor: 2.809

6.  Lifestyle factors and risk for colorectal polyps and cancer at index colonoscopy in a FIT-positive screening population.

Authors:  Dora Colussi; Margherita Fabbri; Rocco Maurizio Zagari; Amedeo Montale; Franco Bazzoli; Luigi Ricciardiello
Journal:  United European Gastroenterol J       Date:  2018-03-08       Impact factor: 4.623

7.  Colorectal polyp model established by transplacental BMP4 RNAi.

Authors:  Xin Jin; Zhongmei Chen; Li Xiang; Qing Luo; Zhenghua Guo; Xionghui Ding; Xianqing Jin
Journal:  Mol Med Rep       Date:  2014-05-07       Impact factor: 2.952

8.  Awareness of Lifestyle and Colorectal Cancer Risk: Findings from the BeWEL Study.

Authors:  Annie S Anderson; Stephen Caswell; Maureen Macleod; Angela M Craigie; Martine Stead; Robert J C Steele
Journal:  Biomed Res Int       Date:  2015-10-04       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.